Kevin Judice - Dice Molecules CEO Founder
| DICEDelisted Stock | USD 47.55 0.00 0.00% |
Insider
Kevin Judice is CEO Founder of Dice Molecules Holdings
| Age | 59 |
| Phone | 650 566 1402 |
| Web | https://www.dicemolecules.com |
Kevin Judice Latest Insider Activity
Tracking and analyzing the buying and selling activities of Kevin Judice against Dice Molecules stock is an integral part of due diligence when investing in Dice Molecules. Kevin Judice insider activity provides valuable insight into whether Dice Molecules is net buyers or sellers over its current business cycle. Note, Dice Molecules insiders must abide by specific rules, including filing SEC forms every time they buy or sell Dice Molecules'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Kevin Judice over six months ago Sale by Kevin Judice of 13698 shares of Dice Molecules |
Dice Molecules Management Efficiency
The company has return on total asset (ROA) of (0.1402) % which means that it has lost $0.1402 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.216) %, meaning that it created substantial loss on money invested by shareholders. Dice Molecules' management efficiency ratios could be used to measure how well Dice Molecules manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 13.27 M in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest the company is not taking enough advantage from borrowing. Dice Molecules Holdings has a current ratio of 23.14, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Dice Molecules until it has trouble settling it off, either with new capital or with free cash flow. So, Dice Molecules' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Dice Molecules Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Dice to invest in growth at high rates of return. When we think about Dice Molecules' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| James Spudich | Cytokinetics | 82 | |
| Oxana Beskrovnaya | Dyne TherapeuticsInc | 63 | |
| Jens Okkels | Ascendis Pharma AS | 63 | |
| Behrad Derakhshan | Edgewise Therapeutics | 44 | |
| Amy JudgePrein | Immunocore Holdings | N/A | |
| Christopher MD | Nuvalent | 55 | |
| Marvin Caruthers | Viridian Therapeutics | 84 | |
| Jaa Roberson | Day One Biopharmaceuticals | N/A | |
| Shauna Horvath | Amylyx Pharmaceuticals | N/A | |
| Gina Mazzariello | Amylyx Pharmaceuticals | 53 | |
| Carrie MBA | Viridian Therapeutics | N/A | |
| Eric Olson | Viridian Therapeutics | N/A | |
| Kari JD | Cytokinetics | N/A | |
| MD MBA | Pliant TherapeuticsInc | 47 | |
| Mike Ouimette | Pliant TherapeuticsInc | 51 | |
| Neeraj Teotia | Arcellx | 49 | |
| Kristian Reich | MoonLake Immunotherapeutics | 58 | |
| Lotte Sonderbjerg | Ascendis Pharma AS | 63 | |
| Harp MBA | VaxcyteInc | 51 | |
| Ashish MBA | VaxcyteInc | 52 | |
| MBA JD | Ventyx Biosciences | 56 | |
Management Performance
| Return On Equity | -0.22 | |||
| Return On Asset | -0.14 |
Dice Molecules Holdings Leadership Team
Elected by the shareholders, the Dice Molecules' board of directors comprises two types of representatives: Dice Molecules inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Dice. The board's role is to monitor Dice Molecules' management team and ensure that shareholders' interests are well served. Dice Molecules' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dice Molecules' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kevin Judice, CEO Founder | ||
| Scott Robertson, Chief Officer | ||
| Timothy MD, Chief Officer | ||
| John Jacobsen, Chief Officer | ||
| Mary JD, G Counsel | ||
| Venkat Thalladi, VP CMC | ||
| Paul Fatheree, VP Chemistry |
Dice Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Dice Molecules a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.22 | |||
| Return On Asset | -0.14 | |||
| Current Valuation | 2.27 B | |||
| Shares Outstanding | 47.76 M | |||
| Shares Owned By Insiders | 3.15 % | |||
| Shares Owned By Institutions | 96.85 % | |||
| Number Of Shares Shorted | 4.88 M | |||
| Price To Book | 5.91 X | |||
| Price To Sales | 699.00 X | |||
| Gross Profit | (56.08 M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Dice Molecules in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Dice Molecules' short interest history, or implied volatility extrapolated from Dice Molecules options trading.
Pair Trading with Dice Molecules
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dice Molecules position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dice Molecules will appreciate offsetting losses from the drop in the long position's value.Moving together with Dice Stock
| 0.76 | ARTE | Artemis Strategic | PairCorr |
Moving against Dice Stock
| 0.76 | BA | Boeing Earnings Call Tomorrow | PairCorr |
| 0.59 | APAC | Stonebridge Acquisition Symbol Change | PairCorr |
| 0.45 | TRCA | Twin Ridge Capital | PairCorr |
The ability to find closely correlated positions to Dice Molecules could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dice Molecules when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dice Molecules - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dice Molecules Holdings to buy it.
The correlation of Dice Molecules is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dice Molecules moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dice Molecules Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dice Molecules can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Dice Molecules Holdings information on this page should be used as a complementary analysis to other Dice Molecules' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in Dice Stock
If you are still planning to invest in Dice Molecules Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dice Molecules' history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |